Primary Job Title President & CEO Primary Organization 
Orexigen Therapeutics
Location La Jolla, California, United States Regions Greater San Diego Area, West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Michael Narachi has served as our President and Chief Executive Officer and a member of our board of directors since March 2009. Previously, Michael served as Chairman, Chief Executive Officer and President of Ren Pharmaceuticals, Inc., a private biotechnology company, from November 2006 to March 2009.
From August 2002 to January 2008, Michael
served as chairman of the board of directors of Naryx Pharma, Inc., a private pharmaceutical company. In 2004, Michael retired as an officer and Vice President of Amgen Inc., a leading therapeutics company, where he served as General Manager of Amgen’s Anemia Business from 1999 to 2003.
Michael joined Amgen in 1984 and held various positions throughout the organization including: Product Development Team Leader for NEUPOGEN® Director of Clinical Operations in Thousand Oaks, CA and Cambridge, UK; Vice President of Development and Representative Director for Amgen Japan; Head of Corporate Strategic Planning; Chief Operations Officer of Amgen BioPharma; and Vice President, Licensing and Business Development. Michael currently serves on the board of directors of Celladon Corporation, a publicly traded biotechnology company. Michael received a B.S. in Biology and an M.A. degree in Biology and Genetics from the University of California at Davis. Michael received an M.B.A. from the Anderson Graduate School of Management at University of California, Los Angeles .
